20.4 C
New York
Thursday, June 18, 2026

Tag: food

Escape the Everyday Routine: Summer Travel Experiences Worth Logging Off For

This summer, make an effort to step away from daily distractions and reconnect with yourself, your passions and the moments that matter most.

Five Guys Earns Great Place To Work Certification™

Five Guys Enterprises LLC corporate and company-owned store teams say Five Guys is a great place to work for the ninth consecutive year.

The CareBridge Group Pivots “Community Access Coalition” into Direct Grant Funding Engine; Invites Florida Nonprofits to Apply for $8.46 Million in Year 1 Capital

Bypassing municipal bureaucracy, the elite healthcare execution firm calls on operational nonprofits in Central Florida and Duval County to secure immediate, privately funded grants...

Saputo Issues its 2026 Promise Report

MONTRÉAL, June 08, 2026 (GLOBE NEWSWIRE) -- On June 4, 2026, Saputo Inc. (TSX: SAP) (we, Saputo or the Company) issued its 2026 Saputo Promise Report, which highlights progress in key Environmental, Social, and Governance (ESG) priorities that support operational resilience, disciplined long-term growth, and sustainable value creation.

Yogurtland Teams Up with Disney and Pixar’s “Toy Story 5” for a Playful Frozen Yogurt Collaboration Ahead of the Film’s Theatrical Release on June...

Three new limited-time flavors, limited collectible in-store giveaways, and exclusive digital content launch June 8FARMERS BRANCH, Texas, June 8, 2026 /PRNewswire/ -- Yogurtland, the...

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks.Delivers up to 2x increase in...

Phenomenex Introduces Luna Omega HILIC LC Columns to Increase Sensitivity and Consistency in Polar Compound Analysis

Enhanced Polar Compound Retention and SeparationTORRANCE, Calif., June 8, 2026 /CNW/ -- Phenomenex Inc., a Danaher Company and a global leader in the research...

Say ‘Bello!’ to the Minions & Monsters Meal, Only at Wendy’s

Wendy's joins Illumination's Minions & Monsters with a custom menu lineup, exclusive collectibles and a drive-thru takeover in Los AngelesFresh Facts:Get ready to experience...

Phenomenex Introduces Luna Omega HILIC LC Columns to Increase Sensitivity and Consistency in Polar Compound Analysis

Enhanced Polar Compound Retention and SeparationTORRANCE, Calif., June 8, 2026 /PRNewswire/ -- Phenomenex Inc., a Danaher Company and a global leader in the research...

Phenomenex Introduces Luna Omega HILIC LC Columns to Increase Sensitivity and Consistency in Polar Compound Analysis

Enhanced Polar Compound Retention and SeparationTORRANCE, Calif., June 8, 2026 /PRNewswire/ -- Phenomenex Inc., a Danaher Company and a global leader in the research...

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Einride and Scan Sverige Partner to Electrify Refrigerated Freight

The addition of Scan Sverige to Einride's growing portfolio of customers highlights the rising demand for scalable, fossil-free freight solutions in high-volume supply chains...

DCH Motors Rebrands as DCH Mobility, Signalling Strategic Shift towards a Smart Mobility Ecosystem

HONG KONG, June 8, 2026 /PRNewswire/ -- To adapt to the rapidly evolving mobility needs of the regional market, Dah Chong Hong Motors (DCH...

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) lyophilized vial for intravenous administration.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFood